Full-length MSP1 is a major target of protective immunity after controlled human malaria infection

Author:

Rosenkranz Micha1ORCID,Nkumama Irene N23ORCID,Ogwang Rodney3,Kraker Sara1ORCID,Blickling Marie1ORCID,Mwai Kennedy34,Odera Dennis3,Tuju James35,Fürle Kristin1ORCID,Frank Roland1,Chepsat Emily3,Kapulu Melissa C3,Study Team CHMI-SIKA3ORCID,Osier Faith HA36ORCID

Affiliation:

1. Centre of Infectious Diseases, Heidelberg University Hospital

2. B Cell Immunology, German Cancer Research Centre, Heidelberg, Germany

3. Centre for Geographic Medicine Research (Coast), Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya

4. Epidemiology and Biostatistics Division, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa

5. Department of Biotechnology and Biochemistry, Pwani University, Kilifi, Kenya

6. Department of Life Sciences, Imperial College London

Abstract

The merozoite surface protein 1 (MSP1) is the most abundant protein on the surface of the invasive merozoite stages ofPlasmodium falciparumand has long been considered a key target of protective immunity. We used samples from a single controlled human malaria challenge study to test whether the full-length version of MSP1 (MSP1FL) induced antibodies that mediated Fc-IgG functional activity in five independent assays. We found that anti-MSP1FLantibodies induced complement fixation via C1q, monocyte-mediated phagocytosis, neutrophil respiratory burst, and natural killer cell degranulation as well as IFNγ production. Activity in each of these assays was strongly associated with protection. The breadth of MSP1-specific Fc-mediated effector functions was more strongly associated with protection than the individual measures and closely mirrored what we have previously reported using the same assays against merozoites. Our findings suggest that MSP1FLis an important target of functional antibodies that contribute to a protective immune response against malaria.

Funder

Alexander von Humboldt Foundation

Wellcome Trust

EC |H2020 | ERA-LEARN | European and Developing Countries Clinical Trials Partnership

NIHR Global Health Research Unit

DELTAS Africa Initiative

Publisher

Life Science Alliance, LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3